本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oncolytics Biotech Inc

1.06
-0.0229-2.12%
成交量:20.31万
成交额:21.58万
市值:1.07亿
市盈率:-3.91
高:1.10
开:1.08
低:1.05
收:1.08
52周最高:1.53
52周最低:0.3258
股本:1.01亿
流通股本:9,362.53万
量比:0.27
换手率:0.22%
股息:- -
股息率:- -
每股收益(TTM):-0.2701
每股收益(LYR):-0.2881
净资产收益率:-249.28%
总资产收益率:-74.56%
市净率:24.34
市盈率(LYR):-3.67

数据加载中...

2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]